keyword
https://read.qxmd.com/read/38623646/extrusion-and-chlorogenic-acid-treatment-increase-the-ordered-structure-and-resistant-starch-levels-in-rice-starch-with-amelioration-of-gut-lipid-metabolism-in-obese-rats
#21
JOURNAL ARTICLE
Xixi Zeng, Ling Chen, Bo Zheng
Dietary interventions are receiving increasing attention for maintaining host health and diminishing disease risk. This study endeavored to elucidate the intervention effect of chlorogenic acid coupled with extruded rice starch (CGA-ES) in mitigating lipid metabolism disorders induced by a high-fat diet (HFD) in rats. First, a significant increase in resistant starch (RS) and a decrease in the predicted glycemic index (pGI) were observed in CGA-ES owing to the formation of an ordered structure (Dm, single helix, and V-type crystalline structure) and partly released CGA...
April 16, 2024: Food & Function
https://read.qxmd.com/read/38622040/corrigendum-to-imeglimin-improves-systemic-metabolism-by-targeting-brown-adipose-tissue-and-gut-microbiota-in-obese-model-mice-metabolism-153-april-2024-155796
#22
Motoharu Awazawa, Maya Matsushita, Ikumi Nomura, Naoki Kobayashi, Miwa Tamura-Nakano, Yuriko Sorimachi, Keiyo Takubo, Kohjiro Ueki
No abstract text is available yet for this article.
April 15, 2024: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/38619583/impacts-of-liver-macrophages-gut-microbiota-and-bile-acid-metabolism-on-the-differences-in-ihfc-diet-induced-mash-progression-between-tsno-and-tsod-mice
#23
JOURNAL ARTICLE
Naoya Igarashi, Kaichi Kasai, Yuki Tada, Koudai Kani, Miyuna Kato, Shun Takano, Kana Goto, Yudai Matsuura, Mayuko Ichimura-Shimizu, Shiro Watanabe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai
BACKGROUND: Tsumura-Suzuki non-obese (TSNO) mice exhibit a severe form of metabolic dysfunction-associated steatohepatitis (MASH) with advanced liver fibrosis upon feeding a high-fat/cholesterol/cholate-based (iHFC) diet. Another ddY strain, Tsumura-Suzuki diabetes obese (TSOD) mice, are impaired in the progression of iHFC diet-induced MASH. AIM: To elucidate the underlying mechanisms contributing to the differences in MASH progression between TSNO and TSOD mice...
April 15, 2024: Inflammation Research: Official Journal of the European Histamine Research Society ... [et Al.]
https://read.qxmd.com/read/38618675/punicic-acid-ameliorates-obesity-related-hyperlipidemia-and-fatty-liver-in-mice-via-regulation-of-intestinal-flora-and-lipopolysaccharide-related-signaling-pathways
#24
JOURNAL ARTICLE
Liping Chen, Yifan Lei, Changxin Lu, Dingyang Liu, Wenyu Ma, Hengqian Lu, Yongzhong Wang
Punicic acid (PA), mainly found in pomegranate seed oil (PSO), has attracted increasing attention due to its potential to mitigate obesity. The regulation of intestinal microflora was identified as a crucial factor and an effective strategy to reverse obesity-related hyperlipidemia and non-alcoholic fatty liver disease (NAFLD). To assess the impact of PSO on hyperlipidemia related to obesity, we investigated the hepatic lipid status and gut microbiota regulation in mice over 13 weeks of feeding a high-fructose high-fat diet (HFHFD)...
April 15, 2024: Food & Function
https://read.qxmd.com/read/38618281/synthesis-and-anti-diabetic-activity-of-an-8-purine-derivative-as-a-novel-dpp-4-inhibitor-in-obese-diabetic-z%C3%A3-cker-rats
#25
JOURNAL ARTICLE
Meriem Chayah, Angélica Luque-González, Verónica Gómez-Pérez, Diego Salagre, Amjad Al-Shdaifat, Joaquín María Campos, Ana Conejo-García, Ahmad Agil
Type 2 diabetes mellitus (T2DM) is one of the world's principal metabolic diseases characterized by chronic hyperglycemia. The gut incretin hormones, glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP), which has been proposed as a new treatment for T2DM, are extensively metabolized by Dipeptidyl peptidase 4 (DPP-4). Inhibitors of DPP-4 block the degradation of GLP-1 and GIP and may increase their natural circulating levels, favoring glycemic control in T2DM. A novel and potent selective inhibitor of DPP-4 with an 8-purine derived structure ( 1 ) has been developed and tested in vitro and in vivo in Zücker obese diabetic fatty (ZDF) rats, an experimental model of the metabolic syndrome and T2DM to assess the inhibitory activity using vildagliptin as reference standard...
2024: Drug Design, Development and Therapy
https://read.qxmd.com/read/38617293/loss-of-paneth-cells-dysregulates-gut-ilc-subsets-and-enhances-weight-gain-response-to-high-fat-diet-in-a-mouse-model
#26
Marisa R Joldrichsen, Eunsoo Kim, Haley E Steiner, Yea Ji Jeong, Christopher Premanandan, Willa Hsueh, Ouliana Ziouzenkova, Estelle Cormet-Boyaka, Prosper N Boyaka
Obesity has been associated with dysbiosis, but innate mechanisms linking intestinal epithelial cell subsets and obesity remain poorly understood. Using mice lacking Paneth cells (Sox9 ΔIEC mice), small intestinal epithelial cells specialized in the production of antimicrobial products and cytokines, we show that dysbiosis alone does not induce obesity or metabolic disorders. Loss of Paneth cells reduced ILC3 and increased ILC2 numbers in the intestinal lamina propria. High-fat diet (HFD) induced higher weight gain and more severe metabolic disorders in Sox9 ΔIEC mice...
April 1, 2024: bioRxiv
https://read.qxmd.com/read/38614956/gut-bacteriome-and-mood-disorders-in-women-with-pcos
#27
JOURNAL ARTICLE
S Lee, M V Tejesvi, E Hurskainen, O Aasmets, J Plaza-Díaz, S Franks, L Morin-Papunen, J S Tapanainen, T S Ruuska, S Altmäe, E Org, A Salumets, R K Arffman, T T Piltonen
STUDY QUESTION: How does the gut bacteriome differ based on mood disorders (MDs) in women with polycystic ovary syndrome (PCOS), and how can the gut bacteriome contribute to the associations between these two conditions? SUMMARY ANSWER: Women with PCOS who also have MDs exhibited a distinct gut bacteriome with reduced alpha diversity and a significantly lower abundance of Butyricicoccus compared to women with PCOS but without MDs. WHAT IS KNOWN ALREADY: Women with PCOS have a 4- to 5-fold higher risk of having MDs compared to women without PCOS...
April 13, 2024: Human Reproduction
https://read.qxmd.com/read/38614647/future-therapies-for-obesity
#28
REVIEW
Eka Melson, Alexander Dimitri Miras, Dimitris Papamargaritis
Obesity is a chronic disease associated with increased morbidity and mortality. Bariatric surgery can lead to sustained long-term weight loss (WL) and improvement in multiple obesity-related complications, but it is not scalable at the population level. Over the past few years, gut hormone-based pharmacotherapies for obesity and type 2 diabetes mellitus (T2DM) have rapidly evolved, and combinations of glucagon-like peptide 1 (GLP1) with other gut hormones (glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) as dual or triple agonists are under investigation to enhance and complement the effects of GLP1 on WL and obesity-related complications...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614167/extraction-structures-biological-effects-and-potential-mechanisms-of-momordica-charantia-polysaccharides-a-review
#29
REVIEW
Zuomin Hu, Yidan Luo, Yuchi Wu, Dandan Qin, Feiyan Yang, Feijun Luo, Qinlu Lin
Momordica charantia L. is a kind of vegetable with medicinal value. As the main component of the vegetable, Momordica charantia polysaccharides (MCPs) mainly consist of galactose, galacturonic acid, xylose, rhamnose, mannose and the molecular weight range is 4.33 × 103 -1.16 × 106  Da. MCPs have been found to have various biological activities in recent years, such as anti-oxidation, anti-diabetes, anti-brain injury, anti-obesity, immunomodulatory and anti-inflammation...
April 11, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38613104/influence-of-bariatric-surgery-on-gut-microbiota-composition-and-its-implication-on-brain-and-peripheral-targets
#30
REVIEW
Sevag Hamamah, Andras Hajnal, Mihai Covasa
Obesity remains a significant global health challenge, with bariatric surgery remaining as one of the most effective treatments for severe obesity and its related comorbidities. This review highlights the multifaceted impact of bariatric surgery beyond mere physical restriction or nutrient malabsorption, underscoring the importance of the gut microbiome and neurohormonal signals in mediating the profound effects on weight loss and behavior modification. The various bariatric surgery procedures, such as Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), act through distinct mechanisms to alter the gut microbiome, subsequently impacting metabolic health, energy balance, and food reward behaviors...
April 5, 2024: Nutrients
https://read.qxmd.com/read/38613071/the-role-of-gut-microbiota-nutrition-and-physical-activity-in-depression-and-obesity-interdependent-mechanisms-co-occurrence
#31
REVIEW
Klaudia Sochacka, Agata Kotowska, Sabina Lachowicz-Wiśniewska
Obesity and depression are interdependent pathological disorders with strong inflammatory effects commonly found worldwide. They determine the health status of the population and cause key problems in terms of morbidity and mortality. The role of gut microbiota and its composition in the treatment of obesity and psychological factors is increasingly emphasized. Published research suggests that prebiotic, probiotic, or symbiotic preparations can effectively intervene in obesity treatment and mood-dysregulation alleviation...
April 2, 2024: Nutrients
https://read.qxmd.com/read/38613011/a-comparative-analysis-between-whole-chinese-yam-and-peeled-chinese-yam-their-hypolipidemic-effects-via-modulation-of-gut-microbiome-in-high-fat-diet-fed-mice
#32
JOURNAL ARTICLE
Qiqian Feng, Jinquan Lin, Zhitao Niu, Tong Wu, Qun Shen, Dianzhi Hou, Sumei Zhou
Chinese yam is a "medicine food homology" food with medical properties, but little is known about its health benefits on hyperlipidemia. Furthermore, the effect of peeling processing on the efficacy of Chinese yam is still unclear. In this study, the improvement effects of whole Chinese yam (WY) and peeled Chinese yam (PY) on high-fat-diet (HFD)-induced hyperlipidemic mice were explored by evaluating the changes in physiological, biochemical, and histological parameters, and their modulatory effects on gut microbiota were further illustrated...
March 27, 2024: Nutrients
https://read.qxmd.com/read/38612951/effects-of-soluble-dextrin-fiber-from-potato-starch-on-body-weight-and-associated-gut-dysbiosis-are-evident-in-western-diet-fed-mice-but-not-in-overweight-obese-children
#33
JOURNAL ARTICLE
Paweł Czarnowski, Aneta Bałabas, Zbigniew Kułaga, Maria Kulecka, Krzysztof Goryca, Kazimiera Pyśniak, Katarzyna Unrug-Bielawska, Anna Kluska, Katarzyna Bagińska-Drabiuk, Maria Głowienka-Stodolak, Magdalena Piątkowska, Michalina Dąbrowska, Natalia Żeber-Lubecka, Aldona Wierzbicka-Rucińska, Aneta Kotowska, Sebastian Więckowski, Michał Mikula, Janusz Kapuśniak, Piotr Socha, Jerzy Ostrowski
BACKGROUND: The study investigated the impact of starch degradation products (SDexF) as prebiotics on obesity management in mice and overweight/obese children. METHODS: A total of 48 mice on a normal diet (ND) and 48 on a Western diet (WD) were divided into subgroups with or without 5% SDexF supplementation for 28 weeks. In a human study, 100 overweight/obese children were randomly assigned to prebiotic and control groups, consuming fruit and vegetable mousse with or without 10 g of SDexF for 24 weeks...
March 22, 2024: Nutrients
https://read.qxmd.com/read/38612556/does-resveratrol-improve-metabolic-dysfunction-associated-steatotic-liver-disease-masld
#34
REVIEW
Kamila Kasprzak-Drozd, Przemysław Niziński, Paulina Kasprzak, Adrianna Kondracka, Tomasz Oniszczuk, Agata Rusinek, Anna Oniszczuk
Metabolic dysfunction-associated steatotic liver disease (MASLD) is influenced by a variety of factors, including environmental and genetic factors. The most significant outcome is the alteration of free fatty acid and triglyceride metabolism. Lipotoxicity, impaired autophagy, chronic inflammation, and oxidative stress, as well as coexisting insulin resistance, obesity, and changes in the composition of gut microbiota, are also considered crucial factors in the pathogenesis of MASLD. Resveratrol is a polyphenolic compound that belongs to the stilbene subgroup...
March 27, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612504/underlying-mechanisms-behind-the-brain-gut-liver-axis-and-metabolic-associated-fatty-liver-disease-mafld-an-update
#35
REVIEW
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho
Metabolic-associated fatty liver disease (MAFLD) includes several metabolic dysfunctions caused by dysregulation in the brain-gut-liver axis and, consequently, increases cardiovascular risks and fatty liver dysfunction. In MAFLD, type 2 diabetes mellitus, obesity, and metabolic syndrome are frequently present; these conditions are related to liver lipogenesis and systemic inflammation. This study aimed to review the connection between the brain-gut-liver axis and MAFLD. The inflammatory process, cellular alterations in hepatocytes and stellate cells, hypercaloric diet, and sedentarism aggravate the prognosis of patients with MAFLD...
March 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612453/the-reduced-gut-lachnospira-species-is-linked-to-liver-enzyme-elevation-and-insulin-resistance-in-pediatric-fatty-liver-disease
#36
JOURNAL ARTICLE
Ching-Chung Tsai, Min-Hsi Chiu, Ho-Poh Kek, Ming-Chun Yang, Yu-Tsun Su, Hsien-Kuan Liu, Ming-Shiang Wu, Yao-Tsung Yeh
The objective of this study was to investigate gut dysbiosis and its metabolic and inflammatory implications in pediatric metabolic dysfunction-associated fatty liver disease (MAFLD). This study included 105 children and utilized anthropometric measurements, blood tests, the Ultrasound Fatty Liver Index, and fecal DNA sequencing to assess the relationship between gut microbiota and pediatric MAFLD. Notable decreases in Lachnospira spp., Faecalibacterium spp., Oscillospira spp., and Akkermansia spp. were found in the MAFLD group...
March 25, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611428/the-probiotic-kluyveromyces-lactis-jsa-18-alleviates-obesity-and-hyperlipidemia-in-high-fat-diet-c57bl-6j-mice
#37
JOURNAL ARTICLE
Yingxiang Hong, Guodong Song, Xiaoqian Feng, Jialei Niu, Lu Wang, Caini Yang, Xuegang Luo, Sa Zhou, Wenjian Ma
Obesity poses a significant threat to various health conditions such as heart diseases, diabetes, high blood pressure, and heart attack, with the gut microbiota playing a crucial role in maintaining the body's energy balance. We identified a novel probiotic fungal strain, Kluyveromyces lactis JSA 18 (K. lactis ), which was isolated from yak milk and was found to possess anti-obesity properties. Additionally, Lactobacillus plantarum CGMCC 8198 (LP8198) from our previous study was also included to evaluate its anti-obesity properties...
April 7, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38611345/the-degree-of-inulin-polymerization-is-important-for-short-term-amelioration-of-high-fat-diet-hfd-induced-metabolic-dysfunction-and-gut-microbiota-dysbiosis-in-rats
#38
JOURNAL ARTICLE
Amin Ariaee, Hannah R Wardill, Anthony Wignall, Clive A Prestidge, Paul Joyce
Inulin, a non-digestible polysaccharide, has gained attention for its prebiotic properties, particularly in the context of obesity, a condition increasingly understood as a systemic inflammatory state linked to gut microbiota composition. This study investigates the short-term protective effects of inulin with different degrees of polymerization (DPn) against metabolic health deterioration and gut microbiota alterations induced by a high-fat diet (HFD) in Sprague Dawley rats. Inulin treatments with an average DPn of 7, 14, and 27 were administered at 1 g/kg of bodyweight to HFD-fed rats over 21 days...
March 28, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38609215/dietary-intake-of-whole-king-oyster-mushroom-pleurotus-eryngii-attenuated-obesity-via-ameliorating-lipid-metabolism-and-alleviating-gut-microbiota-dysbiosis
#39
JOURNAL ARTICLE
Hengjun Du, Yanhui Han, Gaoxing Ma, Chen Tan, Qiuhui Hu, Hang Xiao
There is a growing interest in employing whole food-based strategies to prevent chronic diseases, owing to the potential synergistic interactions among various bioactive components found within whole foods. The current research aimed to determine inhibitory effects of the whole edible mushroom Pleurotus eryngii (WPE) on high-fat diet (HFD)-induced obesity in mice. Our results showed that dietary intake of WPE significantly inhibited the abnormal gain of body weight and adipose tissue weight, improved glucose tolerance, and ameliorated the serum biochemical parameters in HFD-fed mice...
May 2024: Food Research International
https://read.qxmd.com/read/38608580/an-orally-active-carbon-monoxide-releasing-molecule-enhances-beneficial-gut-microbial-species-to-combat-obesity-in-mice
#40
JOURNAL ARTICLE
Djamal Eddine Benrahla, Shruti Mohan, Matija Trickovic, Florence Anne Castelli, Ghida Alloul, Arielle Sobngwi, Rosa Abdiche, Silas Kieser, Vanessa Demontant, Elisabeth Trawinski, Céline Chollet, Christophe Rodriguez, Hiroaki Kitagishi, François Fenaille, Mirko Trajkovski, Roberto Motterlini, Roberta Foresti
Carbon monoxide (CO), a gaseous signaling molecule, has shown promise in preventing body weight gain and metabolic dysfunction induced by high fat diet (HFD), but the mechanisms underlying these effects are largely unknown. An essential component in response to HFD is the gut microbiome, which is significantly altered during obesity and represents a target for developing new therapeutic interventions to fight metabolic diseases. Here, we show that CO delivered to the gut by oral administration with a CO-releasing molecule (CORM-401) accumulates in faeces and enriches a variety of microbial species that were perturbed by a HFD regimen...
April 9, 2024: Redox Biology
keyword
keyword
108661
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.